Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Randomized Phase III Trial Comparing Everolimus Versus Everolimus Plus Bevacizumab for Advanced Renal Cell Carcinoma Progressing After Treatment with Tyrosine Kinase InhibitorsCIRB: Adult CIRB - Late Phase EmphasisLead Group: CALGBStatus: CompletedReview Status: Completed
